In the blockchain sphere many projects claim many use cases to-be-delivered in the future, but rarely ultimately deliver, and as a result, over time—their vision, work and technology fades into obscurity.
The aforementioned result is quite straightforward and easy to understand even for those that are not business-savvy; a project, any project, must provide value to its users, and clients—to stay afloat, or prosper.
By not having a razor-sharp focus on practicality of solutions, attending to existing market demand, or creating new demand—the project or technology is not providing value.
The dHealth team stands out in this respect as the razor-sharp focus on providing value and being practical is clearly demonstrated through a multitude of use cases built. These use cases have been thoroughly tested by our partners, and ready for utilization for businesses and customers.
Even though some of dHealth’s initiatives are exploring the newest, bleeding-edge opportunities & concepts, aimed at creating new market demand, most are, in fact, built around burning issues in the healthcare industry.
Some of these issues dHealth has attended to are data siloing, complex bureaucratic & logistical situations, fraud-related issues.. . Likewise the healthcare industry is plagued by medical data incompleteness, inaccuracy, unverifiability and other data-related flaws.
Data is the most valuable commodity, and this couldn’t be more true for the healthcare industry. With the advent of incredible analytical AI technologies, medical data which is an already incredibly valued commodity—becomes exponentially more valuable, and profitable.
Since the dHealth team has already an impeccable solution for anonymous & trustless data-gathering, which is the CENTIVA Life app, and since there is a continued effort to implement AI with the dHealth technology, there is no question that dHealth is at the forefront of future developments in medicine.
Future vision & goals aside, below you can read more on every use case the dHealth team has deployed, either single-handedly, or in a partnership.
Existing Use Cases
Product & product administration tracking
The logistics within all sectors were dramatically changed and improved when Toyota introduced the first QR code back in 1994. The same is happening with the introduction of blockchain technology into the logistics mix.
dHealth is making great strides on this front ensuring the safe delivery of critically important products, as well as ensuring the products are properly administered, or utilized. Considering the healthcare sector often pertains to life or death situations, the damage inflicted by counterfeit products goes far beyond the reduction in revenue.
That fact aside, in terms of profitability and mitigating losses, counterfeit products approximately cost the healthcare industry a staggering $19 billion a year.
The first project that dHealth realized in the field of product & product administration tracking was the Blockrabies project which was initialized in collaboration with Novartis, University of Basel and Swiss TPH, and sponsored by European and Developing Countries Clinical Trials Partnership.
By utilizing dHealth's Layer1 blockchain, we've built a tracking system for the supply-chain routes of rabies post-exposure prophylaxis medication. This secure, transparent, and easily accessible data repository empowers all project stakeholders to monitor real-time developments related to vaccine transport, vaccine administration, and post-vaccination health status—potentially averting tragedies related to rabies.
The project has been a complete success and is aimed to be institionalized in parts of West Africa in 2024.
The route from raw or pre-processed product or material, to sale of final product and administration involves a myriad of organizations, and their employees. Using the dHealth blockchain to make certain that every step in the supply chain is executed properly, is not only extremely valuable, but also very cost-effective.
Tracking SARS-CoV-2 virality & symptoms
Our partnership with Novartis was a monumental stride in managing SARS-CoV-2 outbreaks.
The joint development of a COVID-19 module—was realized in a Private-Public Partnership with two other partners: University of Basel and Swiss TPH. The successfully performed feat stands as a testament to what collaborative efforts can achieve.
The module gathers users’ symptoms, provides recommendations on how to respond to them, and more. The app has been designed to utilize positive COVID-19 diagnoses at point-of-care to immediately inform all recent contacts of the patients positively diagnosed with COVID-19 so that they can self-isolate, and monitor their symptoms remotely via daily questionnaires.
Since the pandemic's end, the developed module's initial purpose has become defunct.
However, it can easily be appropriated for other diseases—which is the current goal of the dHealth team.
To the great misfortune of all of us, a new Coronavirus strain has recently shown that it could again, threaten the world with lockdowns as well as significant human and economic losses.
This time, however, we are armed with a better understanding of the virus, and we have solutions, such as the COVID-19 module—which will help us defeat it once again.
Similarly to the tracking of products from manufacturing to its final destination, medical or “scientific” samples can also be tracked, cost-effectively so, whilst increasing the efficacy of the whole process.
The increased security & practicality aside, the use case of tracking either samples or products makes even more sense to smaller and medium companies operating in undeveloped countries. This is because such companies in these regions often cannot afford proper database creation & maintenance, and also struggle to attract competent database analysts.
This does not, however, mean that companies in developed countries are strangers to utilization of a decentralized database as opposed to a centralized one. The aforementioned practicality, security and cost-effectiveness has convinced the dHealth partner Gifu university in Japan—to use the dHealth blockchain to track biological samples.
The team is actively looking for new partners to select the dHealth blockchain as their next-generation database, which will propel their organization or company to new heights.
Tracking PCR tests
In collaboration with Roche, dHealth blockchain was successfully utilized to securely generate on-chain and monitor PCR test results which confirm that a person has a low or non-existing coronavirus-related DNA count in their sample.
This ensured the safety of Roche employees, as centralized solutions have been found to be flawed, and jeopardize the health of workers, as well as the public.
Although currently PCR testing has generally become underutilized as opposed to the period at the height of the Coronavirus pandemic, according to newest reports, they might, unfortunately, return.
The PCR solution developed in collaboration with Roche will be available for use by any organization, as well as the general use case of certificates, for either individuals, or products.
In collaboration with Roche, a decentralized patient registry was created that maintains anonymity of the patients’ data and ensures data security.
A decentralized, globally accessible patient registry that is indeed used globally—would be a great boon for the progress in medicine, as it is one step closer to the possibility of patients easily sharing their data for research, with a click of a button.
This concept also includes the patients receiving financial compensation for the anonymous data sharing, whilst ultimately also benefiting them indirectly through better medicine that was created as a result of utilizing the data within the patient registry.
Other conveniences that arise from using such a concept throughout the healthcare industry is the accuracy of the data, ease of verifiability as well as global accessibility of the data. At the current moment, if an individual forgets their vaccine card, neither border control or a hospital has the capability to verify for which diseases an individual is vaccinated for.
Likewise, hospitals often have contradictory information within their system for a single patient, that requires manual correction, and in many countries cross-hospital patient data sharing is non-existent.
That means that patients living in these countries, when visiting a new hospital, have to bring their entire medical documentation with them, otherwise the doctors would make an uninformed medical recommendation or decision.
Exercise can prevent or attenuate a broad spectrum of chronic conditions that are often fatal, such as cardiovascular diseases, type 2 diabetes, colon cancer, and breast cancer. Regular exercise can prevent the incidence of the aforementioned diseases by around 50%, or sometimes more.
Investing into exercise incentivization, often called Move2Earn programs, should be a priority for states, patient groups, and even companies—as regular exercise also increases productivity of employees. Aside from increasing productivity of a company’s employees, it also reduces costs related to sick leaves.
The dHealth team deployed the project’s first Move2Earn use case back in the year 2021 which was providing DHP (Digital Health Points) tokens. At the time the program was called Health2Earn, however, soon with new progress and changes to the program, the program was rebranded to Elevate.
In July 2023 a new version of the Move2Earn program was deployed, branded as UPD8.
The program is ongoing and has a cap of 10,000 beta testers. It provides ACTIV tokens to those that regularly exercise, instead of DHP tokens. The ACTIV tokens are, however, exchangeable for DHP, and they will in the near future provide other benefits to owners of the token.
UPD8 has been updated on a weekly basis, with new modules being added regularly, such as the recently deployed challenges module or the badges module. These modules incentivize UPD8 users to go the extra mile, both figuratively and literally.
The Move2Earn market is relatively young with low saturation, which means effective collaboration leads to value generation on both ends. There is no doubt that in the near future there will be much more than one globally known and used Move2Earn program. Flowing out of the logic of our arguments above, it is mutually beneficial to partner with companies that will also be, or already are, present in the Move2Earn sector.
At the current moment, negotiations are present both with state-level organizations that are eager to efficiently maintain the health of their constituents, as well as private fitness companies looking to integrate the Move2Earn concept into their business model.
Treatment adherence incentivization
The treatment adherence concept, and its related use case—can truly be called Health2Earn, as it rewards patients to stick to their prescribed regimens, in exchange for cryptocurrency.
The pilot project that was a collaboration between dHealth and National Lung Hospital in Vietnam (NLH) tested this use case using DHP tokens as the incentive mechanism and dHealth’s CENTIVA Life app for data collection. The ultimate aim of the project was to encourage treatment adherence in tuberculosis patients. This is because tuberculosis treatment is aggressive and prolonged in duration, with significant detriment if the treatment is not adhered to.
Not only did this project enhance treatment adherence but it also amplified the patient data, enriching the hospital’s reservoir of knowledge for more precise patient treatment and care.
The project was originally intended to include 5,000 Tuberculosis patients at the NLH annually. In parallel, data collection was extended to patients suffering from different respiratory diseases
Although disrupted by the pandemic, the promising program is poised to resume, breathing new life into how blockchain technology can improve patient outcomes.
Data collection incentivization
The previously mentioned pilot project with the NLH also falls in the category of the data collection incentivization use case. Although the program functioned optimally, and was paused due to the pandemic, another pilot project is being developed that is aimed to demonstrate the significant benefits of incentivizing data collection.
In collaboration with Green Consensus, dHealth is working on a blockchain-based data storage solution, which stores feedback from cannabis users on various effects of cannabis, as well as overall health & mood status.
By utilizing the newest analytical AI technologies, it is expected incredible new revelations will be revealed with regards to cannabis health-impacts.
The data from cannabis users is anonymously collected with dHealth’s out-of-the-box CENTIVA Life solution, and the project is run by the first web3 cannabis company in Switzerland—Green Consensus. It is highly likely, new companies will approach dHealth to utilize their cutting-edge solutions, and achieve new breakthroughs in their respective fields.
Although, conceptually, treatment monitoring is very similar to the treatment adherence incentivization use case, the ultimate goal is different. In both use cases patients receive DHP for filling out questionnaires through the CENTIVA Life app, however, that is where similarities end.
The first treatment monitoring use case was deployed in partnership with Roche, and it was aimed at monitoring symptoms and other important information related to hemophilia and spinal muscular atrophy.
The initiative had to be put on hold due to the prevailing geopolitical climate in Ukraine, as that’s where the pilot project was deployed, but the foundation for a decentralized healthcare paradigm has been laid.
Organ Donor Card & Solid Organ Exchange (yet-to-be-deployed)
Our strategic partnership with OrganX embodies the future—specifically, an AI-powered, blockchain-secured solid organ exchange. Operating on a nonprofit basis, this exchange strives to align the varied interests of stakeholders in the transplantation ecosystem, aiming to refine the efficiency, transparency, and security of the organ donation process.
The collaboration with OrganX is yielding the development of a fully virtualized and tokenized transplant ecosystem, grounded in trust.
Another use case that is closely tied to the Solid Organ Exchange is the Organ Donor Card which is being developed in partnership with the Paris Transplant Group. The card guarantees global accessibility, complete privacy, and absolute unforgeability of a person's decision on organ donation.
By optimizing donor-recipient matching, the partnership seeks to enhance the survival rates of both implants and patients, providing a glimmer of hope in an often grim scenario.
Out-of-the-box business solutions
Fitness Incentivisation Ecosystem
In the crossroads of wellness and technological innovation lies the Fitness Incentivisation Ecosystem—a sophisticated framework aimed to help countries, patient groups, companies and organizations in keeping their constituents, members and employees healthy.
The framework involves the utilization of either the already functional UPD8 platform, or the ACTIV token. Unlike the current set-up of UPD8 which aims to motivate anyone in the world to be healthy, and happy, the business solution utilizing this framework can engage select groups, which are selected by the client.
The fitness incentivization ecosystem as a service has three different modes of operation for clients, depending on clients’ needs:
1.) Client can pre-purchase a DHP pool, which is locked, and given out to the select group that signed up with special referral codes
2.) Client can have their own BNB token deployed which is given out to users that signed up with special referral codes
3.) Client can integrate ACTIV tokens into their back-end, pre-purchase DHP due to ACTIV’s capability to be exchanged for DHP
What sets this framework apart is its adaptability. For instance, businesses can issue their own tokens within the ecosystem, tailoring the platform to specific company needs and thereby enriching the 'Move2Earn' concept.
Events and time-specific incentives add another layer of complexity. Special fitness events or initiatives can offer unique rewards like ACTIV tokens or NFTs, which not only drive participation but establish a pattern of continuous, rewarding engagement.
Decentralized Database Solutions
In a world ravenous for accurate and accessible data, the Decentralized Database Solutions emerge as a groundbreaking force. Beyond the simple scope of data storage, this technology provides features with the potential to revolutionize operational efficiencies.
Supply-chain tracking is one of its stellar applications, functioning as more than a digital ledger by offering an immutable, universally verifiable system to trace products from origin to end-user. The tracking can be performed in bulk, or per item, whilst the creation of an inventory is simply a matter of clicking a button.
Due to the nature of the blockchain technology—the data is always available and verifiable.
This unchangeable truth, combined with negligible operational costs related to blockchain transaction costs, courtesy of the dHealth blockchain—makes the solution appealing across sectors.
Digital identity creation extends this utility further, creating not just fraud-proof identification but also assurance. This was exemplified when Roche harnessed the technology for COVID-19 certificates, showcasing a potential that can authenticate credentials on a truly global scale. The road ahead points not just to traceable goods but to identities that can be trusted without reservation.
CENTIVA Life App
The CENTIVA Life app can be loaded as a module into an existing ecosystem. It can also be used as a standalone Androids or iOS app. CENTIVA Life App allows easy and seamless data collection which can be coupled with decentralized digital identity for treatment monitoring, treatment adherence incentivization and other use cases.
The cost of using the CENTIVA Life app is one of the most competitive in the Survey market.
As such its use is beneficial and practical not just for the healthcare industry—but for any industry, and organization.
Accelerated Medical Research
Even though this business solution is in fact a combination of the Decentralized Database Solution and the CENTIVA Life app, it is significant enough to list it as a unique, and to-be popular business solution.
The cutting-edge technology of dHealth can be easily combined to bootstrap regular research studies with a decentralized framework that allows for very efficient data collection, and more importantly—ease of candidate selection.
Candidate selection and gaining consent, is often—a very lengthy and exhaustive process, especially with bigger studies. By utilizing dHealth’s technology, research groups can significantly cut down on costs, allocated resources, and researchers’ time, of any health-care study.
Since the healthcare industry is among the few that pertain to keeping individuals alive and free of debilitating health conditions—it is no wonder a very rigid system has developed, with red tape, and slow adoption of new technologies, and concepts.
When one combines this insight with the observation that the pharmaceuticals & biotechnology sector consistently ranks either first, second, or third among global industries—depending on the emphasis placed on market capitalization, economic impact, and profitability—the conclusion becomes explicit & inescapable.
Use cases & business solutions that focus on alleviating pain points of the healthcare industry, as well as propelling the industry into new heights—generates by far the most value both for humanity, and for shareholders.
The dHealth team aims to do exactly that, and is already enabling both the healthcare & the wellbeing sector—to utilize immensely beneficial concepts, for the benefit of all.
The team is also very eager to implement new use cases which means the list above and article will continue to be updated regularly with new use cases!
Any organization is welcome to reach out to the team, and establish a new use case, or imitate an existing solution that is already deployed.